Sidley advised R-Bridge Healthcare Fund (RBF) on the deal. Mourant advised Natixis Corporate & Investment Banking’s Hong Kong Branch. Reed Smith has advised leading global financial...
R-Bridge Healthcare Fund’s US$120 Million Hybrid Facility
Yisheng Biopharma Co., Ltd.’s US$40 Million Royalty-Backed Financing From R-Bridge Healthcare Fund
Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund. Yisheng Biopharma Co.,...